Clinical Trials Directory

Trials / Completed

CompletedNCT01206452

Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes

Use of Oral Steroids Before Circumferential Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation to Improve Outcomes

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Dhanunjaya Lakkireddy, MD, FACC · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.

Detailed description

The purpose of this study is: 1. To assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation. 2. To measure the inflammatory cytokine (TNF-α, IL-1, IL-6, IL-8) response to radiofrequency ablation for atrial fibrillation with or without prior prednisone treatment.

Conditions

Interventions

TypeNameDescription
DRUGPrednisone60mg of oral prednisone 2 days before procedure, day of procedure, and 1 day after procedure
OTHERPlacebo60mg placebo pill given 2 days before procedure, day of procedure, and 1 day after procedure
PROCEDUREAblation ProcedureAtrial Fibrillation (AF) ablation

Timeline

Start date
2010-09-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2010-09-21
Last updated
2017-05-17
Results posted
2017-05-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01206452. Inclusion in this directory is not an endorsement.